Results 91 to 100 of about 11,489 (185)
Molecular Expression of FGF23 Signaling Components (FGFR1 and α-Klotho) and Their Biochemical Correlation in Early Kidney Impairment [PDF]
Background: Chronic kidney disease and mineral and bone disorder (CKD-MBD) is associated with dysfunction of the FGF23-FGFR1-a-Klotho signaling pathway involved in phosphate regulation and renal function.
Mohamed Y. H., Ahmed M. N.
doaj +1 more source
Background Elevation of FGF23 (fibroblast growth factor 23) and decreased Klotho levels have been associated with various cardiovascular and renal diseases.
Sara Vázquez‐Sánchez +17 more
doaj +1 more source
A Case of Tumor-Induced Osteomalacia Detected by Venous Sampling
Yasuo Horinouchi, Seiji Shiota, Ryo Kaimori, Katsuhiko Yoshimura, Rie Utsunomiya-Nishimizu, Kyoko Yamamoto, Eishi Miyazaki Department of General Medicine, Oita University Faculty of Medicine, Yufu, Oita, 879-5593, JapanCorrespondence: Seiji Shiota ...
Horinouchi Y +6 more
doaj
Yan Chen, Yan-Xia Chen, Chong Huang, Zhi-Bing Duan, Cheng-Yun Xu Department of Nephrology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, 330006, People’s Republic of ChinaCorrespondence: Yan ChenDepartment of ...
Chen Y, Chen YX, Huang C, Duan ZB, Xu CY
doaj
Update on FGF23 and Klotho signaling
Fibroblast growth factor-23 (FGF23) is a bone-derived hormone known to suppress phosphate reabsorption and vitamin D hormone production in the kidney. Klotho was originally discovered as an anti-aging factor, but the functional role of Klotho is still a controversial issue. Three major functions have been proposed, a hormonal function of soluble Klotho,
openaire +2 more sources
Background Compelling evidence suggests that calcium/phosphorus homeostasis-related parameters may be linked to diabetes mellitus and cardiovascular events.
Jiao Bi +6 more
doaj +1 more source
Purpose. To evaluate the diagnostic and prognostic significance of serum FGF23 and VEGF-A levels in newborns with retinopathy of prematurity and to analyze their association with clinical characteristics of the disease. Material and Methods.
A. F. Yusupov +3 more
doaj +1 more source
FGF23 and bone microarchitecture [PDF]
T, Rupp, M, Amling, T, Rolvien
openaire +2 more sources
Burosumab for adults with tumor-induced osteomalacia in China
A better understanding of the benefit of burosumab for treating tumor-induced osteomalacia (TIO) in Chinese patients is needed. The objective of this open-label, multicenter, single-cohort, post-marketing phase 4 study was to assess the efficacy ...
Ruizhi Jiajue +7 more
doaj +1 more source

